EP2594636A4 - Culture medium composition for culturing amnion-derived mesenchymal stem cell, and method for culturing amnion-derived mesenchymal stem cell by using same - Google Patents
Culture medium composition for culturing amnion-derived mesenchymal stem cell, and method for culturing amnion-derived mesenchymal stem cell by using sameInfo
- Publication number
- EP2594636A4 EP2594636A4 EP11807097.8A EP11807097A EP2594636A4 EP 2594636 A4 EP2594636 A4 EP 2594636A4 EP 11807097 A EP11807097 A EP 11807097A EP 2594636 A4 EP2594636 A4 EP 2594636A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- stem cell
- mesenchymal stem
- derived mesenchymal
- amnion
- culturing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100068959A KR101211913B1 (en) | 2010-07-16 | 2010-07-16 | Medium for Culturing Mesenchymal Stem Cells Derived from Amnion and Method for Culturing Mesenchymal Stem Cells Derived from Amnion Using thereof |
PCT/KR2011/005258 WO2012008813A2 (en) | 2010-07-16 | 2011-07-18 | Culture medium composition for culturing amnion-derived mesenchymal stem cell, and method for culturing amnion-derived mesenchymal stem cell by using same |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2594636A2 EP2594636A2 (en) | 2013-05-22 |
EP2594636A4 true EP2594636A4 (en) | 2014-01-22 |
EP2594636B1 EP2594636B1 (en) | 2014-11-26 |
Family
ID=45469969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11807097.8A Not-in-force EP2594636B1 (en) | 2010-07-16 | 2011-07-18 | Culture medium composition for culturing amnion-derived mesenchymal stem cell, and method for culturing amnion-derived mesenchymal stem cell by using same |
Country Status (10)
Country | Link |
---|---|
US (1) | US8871513B2 (en) |
EP (1) | EP2594636B1 (en) |
JP (1) | JP5750159B2 (en) |
KR (1) | KR101211913B1 (en) |
CN (1) | CN103154241B (en) |
AU (1) | AU2011277156B2 (en) |
BR (1) | BR112013001089A2 (en) |
ES (1) | ES2527253T3 (en) |
SG (1) | SG187114A1 (en) |
WO (1) | WO2012008813A2 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101382566B1 (en) * | 2012-02-01 | 2014-04-10 | 동아대학교 산학협력단 | Methods for Culturing Mesenchymal Stem Cell Derived from Placenta Amniotic Membrane and Compositions Comprising Mesenchymal Stem Cell for Repairing Peripheral arterial disease |
JP5926447B2 (en) | 2012-04-18 | 2016-05-25 | アール バイオ カンパニー リミテッドR Bio Co., Ltd. | Method for producing stem cells having a size suitable for intravascular administration |
KR101523040B1 (en) * | 2012-06-26 | 2015-05-26 | 라정찬 | Method for Preparing High Concentration of Stem Cells |
KR20140038236A (en) * | 2012-09-20 | 2014-03-28 | 메디포스트(주) | Method for preparing mesenchymal stem cell aggregates |
CN103333856B (en) * | 2013-07-25 | 2015-08-26 | 张潇潇 | Human umbilical cord mesenchymal stem cell culture medium |
CN104371970B (en) * | 2013-08-15 | 2017-08-04 | 协和华东干细胞基因工程有限公司 | A kind of culture medium for being used to cultivate human amnion membrane |
CN104450608B (en) * | 2013-09-12 | 2017-10-24 | 佛教慈济医疗财团法人 | Promote the adjuvant of Human Meta's stem cell proliferation, expand Human Meta's stem cell methods, medical composition, growth factor and application thereof |
CN103966159B (en) * | 2014-02-13 | 2015-08-05 | 天津和泽干细胞科技有限公司 | Human plactnta Subaerial blue green algae and stem cell bank construction process thereof |
WO2015170347A2 (en) | 2014-05-09 | 2015-11-12 | Reelabs Private Limited | Foetal polymix of mesenchymal stem cells under hypoxic conditions for the treatment of clinical disorders |
CA2958533C (en) | 2014-08-21 | 2023-03-14 | Ajinomoto Co., Inc. | Culture medium for mesenchymal stem cells |
EP3252146B1 (en) * | 2014-10-29 | 2021-09-15 | R Bio Co., Ltd | Medium composition for culturing stem cells |
CN106032527B (en) * | 2015-03-17 | 2019-08-13 | 广州市搏克肿瘤研究所 | It is a kind of tolerance low-density without feeder layer human pluripotent stem cells culture medium |
CN105176912B (en) * | 2015-08-28 | 2019-02-22 | 广州赛莱拉干细胞科技股份有限公司 | A kind of culture medium and its application, preparation method |
KR101779932B1 (en) * | 2015-09-15 | 2017-09-21 | 주식회사 스템랩 | Method for producing of composition for promoting hair growth from human amniotic fluid-derived mesenchymal stem cells with nanog |
CN105420184A (en) * | 2015-12-11 | 2016-03-23 | 郭镭 | Method for culturing umbilical cord mesenchymal stem cells in separated mode from umbilical cord outer layer amnion tissue |
CN105754936B (en) * | 2016-02-25 | 2018-06-08 | 付清玲 | Method of people's inductive pluripotent stem cells induction for mescenchymal stem cell |
US10894947B1 (en) * | 2016-04-29 | 2021-01-19 | Hope Biosciences, Llc | Method for generating protein rich conditioned medium |
US11111480B2 (en) * | 2016-04-29 | 2021-09-07 | Hope Biosctences, Llc | Culture media for multipotent stem cells |
US10959425B2 (en) * | 2016-04-29 | 2021-03-30 | Hope Biosciences, Llc | Method of banking stem cells |
CN110484500A (en) * | 2019-09-23 | 2019-11-22 | 上海亚载生物科技有限公司 | A method of separation and amplification human urine source mescenchymal stem cell |
JP7348892B2 (en) * | 2019-12-30 | 2023-09-21 | 佛教慈濟醫療財團法人 | Compositions and methods for preventing or treating eye diseases |
GB2596216A (en) * | 2021-05-09 | 2021-12-22 | Zhejiang Legou Tech Co Ltd | An elliptical trainer with protective function |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005085422A1 (en) * | 2004-02-27 | 2005-09-15 | Michigan State University | Adult stem cells and uses thereof |
WO2009061024A1 (en) * | 2007-11-09 | 2009-05-14 | Rnl Bio Co., Ltd | Method for isolating and culturing adult stem cells derived from human amniotic epithelium |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080152629A1 (en) * | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
ES2527293T3 (en) | 2004-08-16 | 2015-01-22 | Cellresearch Corporation Pte Ltd | Isolation of stem / progenitor cells of amniotic membrane of the umbilical cord |
KR100679642B1 (en) * | 2005-11-16 | 2007-02-06 | 주식회사 알앤엘바이오 | Multipotent stem cell derived from human adipose tissue and cellular therapeutic agents comprising the same |
ES2711278T3 (en) * | 2005-12-29 | 2019-04-30 | Celularity Inc | Populations of placental stem cells |
KR100818214B1 (en) | 2006-09-29 | 2008-04-01 | 재단법인서울대학교산학협력재단 | Multipotent stem cell derived from amnion or decidua isolated from human term placenta and method for preparing the same |
US20080159999A1 (en) * | 2006-10-23 | 2008-07-03 | Konstantinos Stefanidis | Compositions and methods for identifying, isolating and enriching germline-like stem cells from amniotic fluid |
KR100795708B1 (en) | 2006-12-26 | 2008-01-17 | 주식회사 알앤엘바이오 | Method for isolating and culturing adult stem cells derived from human amniotic epithelium |
-
2010
- 2010-07-16 KR KR1020100068959A patent/KR101211913B1/en active IP Right Grant
-
2011
- 2011-07-18 BR BR112013001089A patent/BR112013001089A2/en not_active IP Right Cessation
- 2011-07-18 US US13/810,334 patent/US8871513B2/en active Active
- 2011-07-18 JP JP2013520643A patent/JP5750159B2/en active Active
- 2011-07-18 ES ES11807097.8T patent/ES2527253T3/en active Active
- 2011-07-18 CN CN201180038199.1A patent/CN103154241B/en not_active Expired - Fee Related
- 2011-07-18 SG SG2013003777A patent/SG187114A1/en unknown
- 2011-07-18 AU AU2011277156A patent/AU2011277156B2/en not_active Ceased
- 2011-07-18 EP EP11807097.8A patent/EP2594636B1/en not_active Not-in-force
- 2011-07-18 WO PCT/KR2011/005258 patent/WO2012008813A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005085422A1 (en) * | 2004-02-27 | 2005-09-15 | Michigan State University | Adult stem cells and uses thereof |
WO2009061024A1 (en) * | 2007-11-09 | 2009-05-14 | Rnl Bio Co., Ltd | Method for isolating and culturing adult stem cells derived from human amniotic epithelium |
Non-Patent Citations (1)
Title |
---|
See also references of WO2012008813A2 * |
Also Published As
Publication number | Publication date |
---|---|
BR112013001089A2 (en) | 2019-09-24 |
WO2012008813A3 (en) | 2012-05-03 |
EP2594636A2 (en) | 2013-05-22 |
CN103154241B (en) | 2015-05-20 |
AU2011277156A1 (en) | 2013-02-07 |
SG187114A1 (en) | 2013-02-28 |
KR101211913B1 (en) | 2012-12-13 |
JP5750159B2 (en) | 2015-07-15 |
WO2012008813A2 (en) | 2012-01-19 |
US8871513B2 (en) | 2014-10-28 |
EP2594636B1 (en) | 2014-11-26 |
ES2527253T3 (en) | 2015-01-21 |
US20130164849A1 (en) | 2013-06-27 |
CN103154241A (en) | 2013-06-12 |
JP2013530721A (en) | 2013-08-01 |
AU2011277156B2 (en) | 2014-06-05 |
KR20120008223A (en) | 2012-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2594636A4 (en) | Culture medium composition for culturing amnion-derived mesenchymal stem cell, and method for culturing amnion-derived mesenchymal stem cell by using same | |
IL273159A (en) | Culture medium composition, and method for culturing cell or tissue using said composition | |
IL288185B1 (en) | Novel methods and culture media for culturing pluripotent stem cells | |
ZA201606403B (en) | Pluripotent stem cell culture on micro-carriers | |
EP2752484A4 (en) | Method for preparing a basic culture medium for mesenchymal stem cells, basic culture medium for mesenchymal stem cells, and cell therapeutic agent cultured and differentiated using same | |
EP2545928A4 (en) | Cell preparation containing mesenchymal stem cells, and method for producing same | |
HK1171790A1 (en) | Cell culture medium for adamts protein expression adamts | |
EP2644694A4 (en) | Method and culture medium for improving pluripotent stem cell differentiation inducing efficiency | |
HK1222198A1 (en) | Culture medium composition for improving regenerative capacity of stem cells, and stem cell culturing method using same | |
EP2843041A4 (en) | Stem cell culture medium and method for culturing stem cells using same | |
GB2497059B (en) | Culture medium, method for culturing listeria,and method for dtecting listeria | |
GB201117469D0 (en) | Culture media for pluripotent stem cells | |
EP2351833A4 (en) | Peptide-containing culture medium for culturing animal cell | |
BR112014000042A2 (en) | composition, cell culture medium, use of a composition, and method for culturing cells | |
EP2638158A4 (en) | Compositions, cells, kits and methods for autologous stem cell therapy | |
GB2482612B (en) | Cell culture support for culturing mesenchymal stem cells | |
EP2511364A4 (en) | Method for culturing cells or microorganisms | |
EP2695934A4 (en) | Animal cell culture kit, method for culturing animal cells, method for selective culture of animal cells and cell differentiation method | |
EP2476748A4 (en) | Culture method for hematopoietic stem cells | |
GB201007861D0 (en) | Dynamic bioreactor for cell culture | |
GB201105442D0 (en) | 3D cell culture method, composition and use for lead candidate selection | |
GB201007863D0 (en) | Bioreactor for cell culture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130115 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20131220 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 5/02 20060101ALI20131216BHEP Ipc: C12N 5/0775 20100101AFI20131216BHEP |
|
17Q | First examination report despatched |
Effective date: 20140526 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20140806 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 698227 Country of ref document: AT Kind code of ref document: T Effective date: 20141215 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602011011799 Country of ref document: DE Effective date: 20150108 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2527253 Country of ref document: ES Kind code of ref document: T3 Effective date: 20150121 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20141126 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 698227 Country of ref document: AT Kind code of ref document: T Effective date: 20141126 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150326 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150326 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150226 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150227 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602011011799 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20150827 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150718 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150731 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150731 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150718 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20160613 Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20110718 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 7 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 8 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20181026 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141126 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20180720 Year of fee payment: 8 Ref country code: DE Payment date: 20180719 Year of fee payment: 8 Ref country code: FR Payment date: 20180726 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20180718 Year of fee payment: 8 Ref country code: GB Payment date: 20180718 Year of fee payment: 8 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170719 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602011011799 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20190718 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190718 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190718 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190718 |